Concepedia

Kendra Sweet

KS

Statistics

Publications

77

Citations

4.4K

H-Index

30

Active since

2012

Affiliations

Moffitt Cancer Center(Current)

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Roswell Park Comprehensive Cancer Center

Cleveland Clinic

Kendra Sweet is an author at Moffitt Cancer Center specializing in medicine, oncology, and hematologic malignancy therapy.

ORCID

Publications per year

2012–2024

77

Publications

77

Eprenetapopt (APR-246) and Azacitidine in <i>TP53</i>-Mutant Myelodysplastic Syndromes

David A. Sallman, Amy E. DeZern, Guillermo Garcia‐Manero et al. · Journal of Clinical Oncology · 2021 · 460 citations · Full text

, , +5

NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021

Daniel A. Pollyea, Dale L. Bixby, Alexander E. Perl et al. · Journal of the National Comprehensive Cancer Network · 2021 · 326 citations · Full text

, , +14

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster et al. · Blood · 2020 · 322 citations · Full text

, , +13

Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

Jerald P. Radich, Michael W. Deininger, Camille N. Abboud et al. · Journal of the National Comprehensive Cancer Network · 2018 · 282 citations · Full text

, , +15

Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Michael W. Deininger, Neil P. Shah, Jessica K. Altman et al. · Journal of the National Comprehensive Cancer Network · 2020 · 265 citations · Full text

, , +15

1–5 of 77